A Rocky Start to 2025
Let’s cut through the corporate veneer: RHI Magnesita’s Q1 2025 trading update reads like a checklist of modern industrial challenges. Trade tensions? Check. Sluggish demand? Check. Margin erosion? Check. But beneath the storm clouds, there’s some intriguing strategic chess being played here.
The Triple Squeeze
The refractory specialist’s first quarter saw:
- Sales volumes shrinking like a cheap sweater
- Project business in glass and non-ferrous metals getting kicked down the calendar
- Indian and Middle Eastern markets turning into a price-cutting battleground
EBITA margins took the expected hit – down 3 percentage points year-on-year by my estimate. The culprits? A perfect storm of underused factories (fixed costs don’t care about idle machines), Chinese imports undercutting prices, and raw material costs that stubbornly refuse to play nice.
The Debt Elephant in the Room
Net debt ballooned to €1.6bn post-Resco acquisition – that’s nearly 3x EBITDA. While management assures us this will deflate to 2.5x by year-end, I’m keeping my spreadsheet handy. The €200m syndicated loan helps, but currency headwinds (looking at you, weak USD) could clip another €15m off EBITA if FX rates hold.
Strategic Plays & Trade War Armour
Localisation as a Shield
Here’s where it gets interesting. While competitors sweat over Trump 2.0 tariffs or EU trade barriers, RHI’s “local for local” strategy acts like Kevlar:
- Vertical integration in raw materials – checkmate to supply chain disruptions
- Resco acquisition creating US production capacity – though the 18-month ramp-up feels glacial
- German plant closures (auf wiedersehen, Wetro) to prune excess capacity
The M&A Gambit
Let’s not gloss over that €391m Resco deal. It’s a classic “buy the customer” move – locking in North American market share while dodging import tariffs. But integrating acquisitions is where many firms stub their toe. The promised synergies need to materialise faster than a TikTok trend to justify that debt load.
H2 or Bust: The 60/40 Profit Split
Management’s guiding toward 35-40% of EBITA in H1, meaning they’re banking on a superhero second half. The playbook?
- Price hikes (good luck with that in a soft market)
- Cost cuts sharper than a Savile Row suit
- Project delays turning into H2 revenue geysers
“We’ve implemented measures to support margins by reducing costs and executing price increases… although downside risks have increased.”
– Stefan Borgas, CEO
Translation: “We’re not out of the woods yet, but we’ve got a bigger machete.”
The Investor’s Checklist
- Watch Chinese refractory exports like a hawk – they’re the canary in this coal mine
- Mark July in your diary – if H1 EBITA doesn’t hit that 35% threshold, guidance could unravel
- Track USD/EUR rates – every 10% move could swing EBITA by €20m+
The Bottom Line
RHI Magnesita is playing multidimensional chess while others play checkers. Yes, the debt’s concerning and H1 looks soggy. But their vertical integration and localisation strategy could pay dividends (literally) as trade wars escalate. This isn’t a stock for the faint-hearted, but for those with a 2-3 year horizon? There’s method in the margin madness.
Now, if you’ll excuse me, I’m off to calculate how many tonnes of refractory it takes to line a path through this particular earnings valley…
